✦ LIBER ✦

P.2.134 Bupropion for the treatment of major depressive disorder characterized by loss of pleasure, interest and energy

Book ID: 118591905
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 120 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(05)80923-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combination of duloxetine and buprop

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

✍ George I. Papakostas; John J. Worthington III; Dan V. Iosifescu; Gustavo Kinrys; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission

Combined cognitive behavioral therapy an

Combined cognitive behavioral therapy and bupropion for the treatment of problematic on-line game play in adolescents with major depressive disorder

✍ Kim, Sun Mi; Han, Doug Hyun; Lee, Young Sik; Renshaw, Perry F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 248 KB

Combined cognitive behavioral therapy an

Combined cognitive behavioral therapy and bupropion for the treatment of problematic on-line game play in adolescents with major depressive disorder

✍ Kim, Sun Mi; Han, Doug Hyun; Lee, Young Sik; Renshaw, Perry F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 248 KB

A Markov cost-utility analysis of escita

A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder*

✍ Armstrong, Edward P.; Malone, Daniel C.; Haim Erder, M. 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 484 KB

Duloxetine for the treatment of major de

Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation

✍ Madelaine M. Wohlreich; Craig H. Mallinckrodt; Apurva Prakash; John G. Watkin; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

P-536 - Immediate-release and extended-r

P-536 - Immediate-release and extended-release formulations of second-generation antidepressants for the treatment of major depressive disorder in adults

✍ M. Van Noord; K. Thaler; L. Morgan; G. Gartlehner 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 92 KB